Target intelligence / Profile preview

RNA, U1 small nuclear 46, pseudogene (RNU1-46P)

Target
RNU1-46P
Molecular classification
Other (non-coding RNA pseudogene)
01

Overview

RNA, U1 small nuclear 46, pseudogene (RNU1-46P) is a pseudogene in the human genome that resembles the genes encoding U1 small nuclear RNAs (snRNAs), which are essential RNA components of the spliceosome complex responsible for pre-mRNA splicing[1][3][6][7]. However, RNU1-46P itself is classified as a pseudogene—meaning it does not encode a functional RNA product and is generally considered non-functional for biological processes. It is not a known therapeutic target, does not have established biological or disease roles, and should not be considered an active molecular target for drug development or biomarker strategies[1][6]. Its main value may be in genome annotation and evolutionary studies rather than in functional biology or medicine. Key clarifications: - RNU1-46P is a pseudogene and does not produce a functional small nuclear RNA[1][6][7]. - It is not considered a therapeutic target, receptor, enzyme, transporter, or any of the commonly druggable target classes. - No associated drugs, mechanism of action, biomarkers, safety concerns, or disease relevance have been reported. - A similar name, RNU1-1, refers to the functional U1 snRNA gene family, but RNU1-46P specifically designates the non-functional (pseudogene) member[3][6][7]. If you are seeking information about the **functional** U1 small nuclear RNA (e.g., "RNA, U1 small nuclear 1"), refer to gene RNU1-1 instead, which is crucial for mRNA splicing, but this does not apply to RNU1-46P[2][5][8].

Other names
RNU1-46P

Beyond the preview

Go deeper on RNA, U1 small nuclear 46, pseudogene (RNU1-46P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 46, pseudogene (RNU1-46P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call